The European Medicines Agency (EMA) revises its guideline on minimizing risk in first-in-human trials to reflect changing practice and in light of a recent tragic incident.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873368 | PMC |
| http://dx.doi.org/10.1002/cpt.899 | DOI Listing |
Publication Analysis
Top Keywords
promoting safe
4
safe early
4
early clinical
4
clinical novel
4
novel drug
4
drug candidates
4
candidates european
4
european union
4
union regulatory
4
regulatory perspective
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!